.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Citi
Fish and Richardson
Cerilliant
US Army
Accenture
UBS
Chubb
Farmers Insurance
Healthtrust

Generated: June 23, 2017

DrugPatentWatch Database Preview

Piroxicam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for piroxicam and what is the scope of piroxicam patent protection?

Piroxicam
is the generic ingredient in two branded drugs marketed by Mylan, Teva Pharms, Egis, Mylan Ireland Ltd, Teva, SCS, Sun Pharm Inds, Flamingo Pharms, Unichem Labs Ltd, Pfizer, Ivax Sub Teva Pharms, Cycle Pharms Ltd, and Watson Labs, and is included in eighteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for piroxicam. Twenty-three suppliers are listed for this compound.

Summary for Generic Name: piroxicam

Tradenames:2
Patents:1
Applicants:13
NDAs:18
Drug Master File Entries: see list15
Suppliers / Packagers: see list23
Bulk Api Vendors: see list90
Clinical Trials: see list14
Patent Applications: see list9,897
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:piroxicam at DailyMed

Pharmacology for Ingredient: piroxicam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
PIROXICAM
piroxicam
CAPSULE;ORAL074287-001May 16, 1996DISCNNoNo► Subscribe► Subscribe
Flamingo Pharms
PIROXICAM
piroxicam
CAPSULE;ORAL207938-002Sep 9, 2016ABRXNoNo► Subscribe► Subscribe
Mylan
PIROXICAM
piroxicam
CAPSULE;ORAL074043-001Sep 22, 1992DISCNNoNo► Subscribe► Subscribe
Watson Labs
PIROXICAM
piroxicam
CAPSULE;ORAL074287-002May 16, 1996DISCNNoNo► Subscribe► Subscribe
Watson Labs
PIROXICAM
piroxicam
CAPSULE;ORAL074460-001Sep 29, 1995DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: piroxicam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19823,674,876► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19823,927,002► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19824,100,347► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19823,591,564► Subscribe
Pfizer
FELDENE
piroxicam
CAPSULE;ORAL018147-002Apr 6, 19823,862,319► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Argus Health
UBS
Express Scripts
Baxter
US Army
Merck
Mallinckrodt
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot